TORONTO — If U.S.-based AquaBounty Technologies gets Food and Drug Administration (FDA) approval, it plans to sell GMO salmon eggs to fish farmers worldwide, reports CBC News.
“We expect there will be people in the United States and Canada, once the product is approved, that will be interested in growing that fish,” said Ron Stotish, CEO of AquaBounty, as quoted in CBC News.
Environmentalists are concerned the fish — that is produced in P.E.I. — could endanger wild Alaskan Salmon, since different areas of the world have various environmental conditions and regulations cannot be monitored or enforced.
The hotly contested product is undergoing FDA approval in the U.S.
For more on GMO salmon, visit CBC News.